Cargando…

Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain

The aim of this study is to characterize the factors related to peptidoglycan metabolism in isogenic hVISA/VISA ST100 strains. Recently, we reported the increase in IS256 transposition in invasive hVISA ST100 clinical strains isolated from the same patient (D1 and D2) before and after vancomycin tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Gregorio, Sabrina, Fernandez, Silvina, Cuirolo, Arabela, Verlaine, Olivier, Amoroso, Ana, Mengin-Lecreulx, Dominique, Famiglietti, Angela, Joris, Bernard, Mollerach, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Mechanisms
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206683/ https://www.ncbi.nlm.nih.gov/pubmed/27991847 http://dx.doi.org/10.1089/mdr.2016.0160

Ejemplares similares

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
por: Lai, Chih-Cheng, et al.
Publicado: (2017)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

1249. Metabolomic Profile of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) in Latin-American MRSA Isolates
por: Castro-Cardozo, Betsy E, et al.
Publicado: (2021)

Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA)
por: McCallin, Shawna, et al.
Publicado: (2022)

Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains
por: Cafiso, Viviana, et al.
Publicado: (2012)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study
por: Martirosov, Dmitriy M., et al.
Publicado: (2017)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
por: Katayama, Yuki, et al.
Publicado: (2016)

Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Su, Michelle, et al.
Publicado: (2021)

In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin
por: Herrera, Melina, et al.
Publicado: (2016)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Comparative Genomics Identifies Novel Genetic Changes Associated with Oxacillin, Vancomycin and Daptomycin Susceptibility in ST100 Methicillin-Resistant Staphylococcus aureus
por: Di Gregorio, Sabrina, et al.
Publicado: (2023)

Clinical, Microbiological, and Genetic Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Teaching Hospital
por: Di Gregorio, Sabrina, et al.
Publicado: (2015)

Detection of Staphylococcus aureus with an intermediate profile to vancomycin (VISA) isolate from Santa Maria, RS
por: Marques, Jaciane Baggiotto, et al.
Publicado: (2013)

Aortic Root Abscess with Aorta to Right Atrium Fistula due to Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Hankinson, Stephen J., et al.
Publicado: (2019)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Intermediate-Type Vancomycin Resistance (VISA) in Genetically-Distinct Staphylococcus aureus Isolates Is Linked to Specific, Reversible Metabolic Alterations
por: Alexander, Elizabeth L., et al.
Publicado: (2014)

Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus
por: Katayama, Yuki, et al.
Publicado: (2017)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin
por: Singh, Madhuri, et al.
Publicado: (2017)

VIM-2–producing Pseudomonas putida, Buenos Aires
por: Almuzara, Marisa, et al.
Publicado: (2007)

Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure
por: Bhardwaj, Pooja, et al.
Publicado: (2017)

American visa
Publicado: (2005)

Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
por: Chacko, Kieran I., et al.
Publicado: (2018)

Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faecium
por: García-Solache, Mónica, et al.
Publicado: (2016)

A Silenced vanA Gene Cluster on a Transferable Plasmid Caused an Outbreak of Vancomycin-Variable Enterococci
por: Sivertsen, Audun, et al.
Publicado: (2016)

Morphological and Biological Characteristics of Staphylococcus aureus Biofilm Formed in the Presence of Plasma
por: Sato, Ayami, et al.
Publicado: (2019)

Alignment of the VISA undulator
por: Ruland, R E, et al.
Publicado: (1999)

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
por: Hu, Qiwen, et al.
Publicado: (2016)

Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
por: Zhang, Shanshan, et al.
Publicado: (2015)

A Peptidoglycan Fragment Triggers β-lactam Resistance in Bacillus licheniformis
por: Amoroso, Ana, et al.
Publicado: (2012)

Active-Site Protonation States in an Acyl-Enzyme Intermediate of a Class A β-Lactamase with a Monobactam Substrate
por: Vandavasi, Venu Gopal, et al.
Publicado: (2016)

Mechanical Design of the VISA Undulator
por: Libkind, M, et al.
Publicado: (1999)

Measurement and Optimization of the VISA Undulator
por: Rakowsky, G, et al.
Publicado: (1999)

Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014)

Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020)

Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
por: Lin, Lee-Chung, et al.
Publicado: (2018)

Photon Beam Diagnostics for VISA FEL-
por: Murokh, A, et al.
Publicado: (1999)

The Global Evolution of Travel Visa Regimes
por: Czaika, Mathias, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lfsabps9g7sd0ov981s6phgqbp